•Diffusion •Convection •Adsorption

•Diffusion •Convection •Adsorption

5/5/2010 Objectives: Renal Replacement • Review the concepts of different Therapies (RRT) for the modalities of RRT Non-Nephrologist • Examine the necessaryyp components involved in RRT • Examine the indications for RRT Kevin Harned, MD • Review particular caveats to specific University of Kentucky Medical Center treatment modalities Division of Nephrology, Bone & Mineral Metabolism November 3, 2009 3 physiologic principles of Physiology: RRT: • Diffusion: Process of movement of •Diffusion molecules across an area due to differences in concentration gradients – Moves from high-to-low concentration until •Convection the concentrations for both areas are equal – Adequate for clearing small molecules (<1kDa) •Adsorption – Na, K, Ca, Creatinine, Urea, Gentamicin Physiology: Physiology: • Convection: Using suction to physically • Adsorption: Binding of substances to pull water across a membrane, and with the surface of the filter/membrane the fluid shift anyygthing else that can “fit” – More a factor of electrical charge of the through the membrane’s pores as it substance, organic vs inorganic (as in rides with the water (aka “Solvent drag”) removal by charcoal filters) – Think of the white-water rafter being “pulled” downstream by the river – Better for clearance of middle molecular weight molecules (up to 60kDa) – Vancomycin, cytokines (IL-1, IL-8, etc) 1 5/5/2010 Physiology: Terminology: • Peritoneal dialysis (PD) • Adsorption: Binding of substances to • Intermittent Hemodialysis (IHD) the surface of the filter/membrane • Continuous Renal Replacement Therapies (CRRT) – More a factor of electrical charge of the – Continuous veno-venous hemofiltration (()CVVH) substance, organic vs inorganic (as in – Continuous veno-venous hemodialysis (CVVHD) removal by charcoal filters) – Continuous veno-venous hemodiafiltration (CVVHDF) – Sustained, low-efficiency daily hemodialysis (SLEDD) – High-volume hemofiltration (HVHF) • Slow continuous ultrafiltration (SCUF) • “Liver Dialysis” − Molecular Adsorption Recirculating System (MARS) Courtesy of WR Clark, CRRT 2007 Symposium − “Prometheus” (Not in the United States) PD: PD: • Diffusion >>> Convection • Can be performed via manual exchanges • Uses peritoneum as a semi-permeable or automated cycler machine at night membrane for exchange • 3 Glucose concentrations: • Fluid infused into abdominal cavity via PD catheter • 15%1.5% •2.5% • Solute clearance is a factor of: • 4.25% • Volume of fluid infused (usually 2-3L) • The higher the Glucose concentration, the more • Time allowed to dwell (factor of the properties of water will be removed from the pt d/t higher the peritoneum) osmolality of the PD fluid compared to the plasma • % of Glucose in fluid (convective component) • Fluid removal solely dependent upon % of Glucose in fluid Typical PD Rx (manual): Typical PD Rx (cycler): • Volume = 2.5L • Volume = 2.5L • Time = Dwell x 3hrs • Time = 1hr 40min fill/dwell; 20min drain • # of exchanges = 3 • Length of tx = 7PM – 7AM • Need 9-12hrs of RRT to be sufficient • Fluid = 1.5% Dianeal • Fluid = 1.5% Dianeal 2 5/5/2010 PD: PD: • D/t logistics of placing PD catheter, as well • Not good candidates if: as its efficiency limitation, PD is not ideal • Morbidly obese (insufficient dose) for the Acute Kidney Injury (AKI) pt • Multiple abdominal surgeries (scarring of requiring RRT peritoneum) • Better if slowly progressed to ESRD • Pt is blind (can’t care for catheter = infxn) • Good candidates if: • Pt has ascites (regardless of etiology) • High-fxn’ing pt (allows them to keep their independence) • Still has residual kidney fxn • Pt’s w/ CHF (fluid shifts are more gentle) PD: IHD: • Complications • Diffusion >>> Convection –PD inadequacy •Ingredients • Peritoneal membrane eventually develops • Vascular Access properties that make clearance inadequate •Bldiilood circuit • Usually d/t numerous episodes of peritonitis • Filter w/ semipermeable membrane – Peritonitis • Dialysate fluid circuit • Approx 1 infxn/15 months • Diffusive component – Encapsulating Peritoneal sclerosis • Ultrafiltrate circuit = fluid removed •<1% of PD pt’s • Convective component • Bowel obstruction, hemorrhagic ascites • Anticoagulation • Mortality 30-50% IHD: Vascular Access IHD: Blood circuit • Temporary dialysis catheter (Uldall, •BFR= Blood Flow Rate Quinton, Vascath) – Target = 300 – 500ml/min • Tunneled dialysis catheter (Cannon, •PA= Arterial port pressure Palindrome, Decathalon) – This is a negative # measured inside the lines of the RRT circuit that represents the amount of suction • Native arterio-venous fistulas (AVF’s) required to physically pull the blood from the patient • Synthetic and native arterio-venous grafts – Goal -75 to -250mmHg (AVG’s) •PV= Venous port pressure – This is a positive # measured inside the lines of the RRT circuit that represents the amount of pressure required to PUSH the blood back to the patient – Goal 100 to 250mmHg 3 5/5/2010 IHD: Blood circuit IHD: Blood circuit • PA alarms ONLY when it is too low (<-250) • PV alarms typically when it is too high – ALWAYS represents an ACCESS problem (>250) • Improper needle placement (AVF/AVG) – ACCESS problem • Insufficient arterial inflow of blood into the • Improper needle placement (AVF/AVG) access (AVF/AVG) • Outflow stenosis (AVG >> AVF) – Venous anastomosis (AVG) • Kink in dialysis catheter – Draining vein (needle stick sites, proximal swing segment • Catheter sucking against interior wall of of transposed brachial-basilic AVF’s, Cephalic Arch, central vein venous stenosis) • Kink in dialysis catheter • Clot at tip of catheter acting as a one-way • Clot inside lumen of tip of catheter obstructing valve outflow – Thrombosis of Venous Drip chamber Caveat to monitoring the IHD: Filter pressures • Each pressure is measured via a line connected to the machine that is screened through a Dialysis discoid filter where the line attaches to the Fluid machine pppump – If these filters get wet (with fluid or blood), they will not be able to permit the air pressure to transmit across properly – Consequently, the machine will give you false readings IHD: Dialysate circuit IHD: Dialysate circuit • DFR = Dialysate Flow Rate • Solutes we can control: – Target = 500-750ml/min – Metabolic acidosis – Provides the DIFFUSION component for solute –K+ clearance – Ca2+ – NO EFFECT ON VOLUME STATUS OF PT –Uremia –Na (somewhat) – Phos (somewhat) 4 5/5/2010 IHD: Filter IHD: Ultrafiltrate circuit • UF = Actual volume removal – Requires CONVECTION to physically pull the fluid from the pt’s blood across the membrane O O O O – Nothing selectively removes just water! 2 2 2 2 H H H H O O O O • Small amount of clearance simply d/t solvent drag 2 2 2 2 H H – Amount of UF entirely dependent on H intravascular volume status of pt and his/her O O O O blood pressure 2 2 2 2 H H H H P OH O O O 2 2 2 2 H – The volume of fluid removed is what leads to U u H H H hypotension, not the actual BFR F m p Continuous Renal Replacement IHD: Anticoagulation Therapies (CRRT) • Heparin = #1 type used worldwide • Continuous veno-venous hemofiltration – Bolus only (CVVH) – Bolus + infusion • Continuous veno-venous hemodialysis – Infusion only (CVVHD) – “Tight” Heparin • Continuous veno-venous hemodiafiltration (CVVHDF) • No anticoagulation • High-volume hemofiltration (HVHF) • Sustained, low-efficiency daily • If already anticoagulated for another hemodialysis (SLEDD) reason, nothing additional is given. CVVH: CVVH: • All CONVECTION • Replacement Fluid Rate/Substitution Fluid • Blood flow rates 150-400ml/min Rate • Uses a higher fluid removal rate than required – Clearance of solutes by solute drag tt“li”to restore “euvolemia” – Mac hine PULLS thi s vol ume and gi ves thi s – Pull 2-6 LITERS from the patient/hr volume back • Requires use of replacement fluid to prevent – No fluid balance is lost/gained patient from becoming hypotensive – Target = 35ml/kg/hr – Most machines BOTH REMOVE AND REPLACE this volume, so the net fluid loss is ZERO •UF – Extra fluid that is NOT replaced, leading to • Net fluid loss = (RFOUT + UF) - RFIN actual water-loss 5 5/5/2010 CVVH: Filter CVVH: • Blood flow rates 150-400ml/min • Uses a higher fluid removal rate than O O O O required to restore “euvolemia” 2 2 2 2 H H H H O O O O – Pull 2-6 LITERS from the patient/hr 2 2 2 2 H H • Requires use of replacement fluid to H prevent patient from becoming O O O O P 2 2 2 2 H H H H OH O O O hypotensive 2 2 2 2 H u H H H m * • Net fluid loss = Total UF rate - Replacement fluid rate p Palevsky, PM; “Continuous Renal Replacement Therapies.” ASN Board Review Course—August 2001. HDCN online symposium. CVVHD: CVVHD: • Diffusion >>> Convection (just like IHD) • Blood flow rate 150-400ml/min • Blood flow rate 150-400ml/min • Solute removal dependent on diffusion across • Solute removal dependent on diffusion across membrane w/ dialysate memb/diltbrane w/ dialysate – Dialysate is counter-current to blood flow in order to maximize concentration gradients across entire length of the – Dialysate is counter-current to blood flow in order to filter maximize concentration gradients across entire length of the – Usually on the order of 1.5-3L/hr filter – Usually on the order of 1.5-3L/hr • UF set only at rate that pt hemodynamically • UF set only at rate that pt hemodynamically can withstand, w/ goal of restoring can withstand, w/ goal of restoring “euvolemia” (0-150ml/hr) “euvolemia” (0-150ml/hr) Palevsky,• PM; Net“Continuous fluid Renal loss Replacement = UF Therapies.” rate ASN Board Review Course—August 2001. HDCN online symposium. CVVHDF:

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us